Skip to content

Assessment of dietary magnesium supplementation on improving glucose metabolism in elderly type 2 diabetics and its cost-effectiveness analysis

Assessment of dietary magnesium supplementation on improving glucose metabolism in elderly type 2 diabetics and its cost-effectiveness analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047680
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-06-30
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

experimental group:Mg supplement

Sponsors

National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed with type 2 diabetes, stable blood sugar control, no serious complications; 2. Over 60 years old; 3. BMI 18.5-28kg/m2; 4. Self care (self action, eating and communication); 5. Normal cognitive ability (MMSE score below mild).

Exclusion criteria

Exclusion criteria: 1. Related diseases affecting gastrointestinal absorption; 2. Abnormal renal function; 3. Abnormal liver function; 4. Cardiovascular and cerebrovascular diseases: in the acute stage of cardiovascular and cerebrovascular diseases, acute coronary syndrome (one month before the study); 5. Malignant tumor; 6. Participate in other clinical trials; 7. Recently taken (1 month before the study) or taking pure magnesium supplement.

Design outcomes

Primary

MeasureTime frame
glucose;insulin;

Countries

China

Contacts

Public ContactYang Lichen

Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention

yanglc@ninh.chinacdc.cn+86 13683341260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026